News from NYU Langone Health
Changing Of The Guard At NYU Langone Health. (AuntMinnie)
(8/15) On September 1, radiation oncologist Alec Kimmelman, MD, PhD, the Anita Steckler and Joseph Steckler Chair, and professor, Department of Radiation Oncology, Perlmutter Cancer Center will become CEO of NYU Langone Health and dean of NYU Grossman School of Medicine, taking over for Robert I. Grossman, MD, dean and CEO, who led the organization from “a small regional hospital” in 2007 to “a leading academic health system” in 2024; Grossman “will assume a new role as executive vice president to the NYU Langone Health board of trustees.”
This Hidden Heart Condition Is Known As A ‘Silent Killer’ – How To Know If You Need Treatment, Even With No Symptoms. (New York Post)
ճ (8/18) Geraldine Ong, MD, clinical associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology and Mark D. Peterson, MD, PhD, professor, Department of Cardiothoracic Surgery, lead the Aortic Center, offering comprehensive care for aortic aneurysms, which are often “silent killers” detected through advanced imaging; they provide personalized treatment plans, including genetic testing, lifestyle recommendations, and minimally invasive procedures like stent grafts, with NYU Langone Health ranked No.1 in cardiology, heart, and vascular surgery by US News & World Report.
Is Paul Goldschmidt At Risk Of Missing Games? (New York Post)
ճ (8/15) Berkcan Akpinar, MD, assistant professor, Department of Orthopedic Surgery, discusses “what the recovery timeline for a knee sprain is after Yankees first baseman Paul Goldschmidt suffered the injury on Wednesday night against the Minnesota Twins.”
Jets’ Tyrod Taylor Done For Rest Of Preseason. (New York Post)
ճ (8/15) Berkcan Akpinar, MD, assistant professor, Department of Orthopedic Surgery, shares with Brandon London “how doctors make the decision to perform knee surgery after Jets back-up quarterback Tyrod Taylor got a knee scope and was ruled out for the remainder of Gang Green’s preseason.”
Bill Gates Meets Willy Wonka: How Epic’s 82-Year-Old Billionaire CEO, Judy Faulkner, Built Her Software Factory. (CNBC)
(8/16) Epic Systems, led by 82-year-old CEO Judy Faulkner, remains a dominant force in healthcare software, particularly in electronic health records (EHR), with its technology used by 42% of acute care hospitals in the U.S. and over 3,300 hospitals globally; Faulkner, who founded the company in 1979, has a succession plan to keep Epic privately held; Robert I. Grossman, MD, dean and CEO, said, “We bet the ranch on Epic, let’s be very honest,” reflecting the high stakes involved in implementing Epic’s EHR systems.
Physician Discusses Benefits Of Nuclear Medicine Stress Tests. (WABC-TV New York)
(8/15) Lawrence Phillips, MD, associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, discussed the importance of nuclear stress tests for detecting severe artery blockages that may not be visible on an EKG, explaining that these tests evaluate if arteries can dilate to meet increased blood needs during exercise or chemical stimulation, which is crucial for patients with heart disease risk factors or exertion-related symptoms; he also addressed new blood pressure guidelines, recommending awareness of lifestyle changes and suggesting that alcohol should be limited due to its potential negative effects on blood pressure, while emphasizing the importance of regular blood pressure monitoring.
Children In A Mental Health Crisis Can Spend Days Languishing In The ER. (NPR)
(8/15) A new study indicates that “children who go to emergency departments in a mental health crisis and need to be hospitalized often end up stuck there for days,” findings that don’t surprise Jennifer Havens, MD, the Arnold Simon Professor of Child and Adolescent Psychiatry, chair, Department of Child and Adolescent Psychiatry, who said, “There’s an enormous problem across the country with a lack of access to mental health services, both on the [inpatient and] outpatient side.”
StockWatch: After FDA Approval, Analysts Predict Blockbuster Sales For Insmed Drug. (Genetic Engineering & Biotechnology News)
(8/17) Insmed received FDA approval for Brinsupri, the first drug for non-cystic fibrosis bronchiectasis (NCFB), with Doreen J. Addrizzo-Harris, MD, professor, Department of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, saying, “For the first time, we have a treatment that directly targets neutrophilic inflammation and addresses a root cause of bronchiectasis exacerbations,” and calling it a potential new standard in NCFB care.
Safeguarding Vulnerability: COVID-19’s Impact On Immunocompromised Patients With Cancer. (Cancer Network)
(8/15) “Immunocompromised individuals face ongoing COVID-19 risks despite vaccination, highlighting the need for tailored public health strategies and innovative therapies,” Dorry L. Segev, MD, PhD, professor, Department of Surgery, Division of Transplant Surgery, professor, Department of Population Health, vice chair for research, Department of Surgery and the Surgical Sciences, “emphasizing that public health initiatives must address the unique vulnerabilities of patients with cancer by implementing tailored preventive measures and policies.”
Long COVID Left Her Son With Debilitating Stomach Pain. Why It’s An ‘Uphill Battle’ For So Many Kids To Get Treated. (Toronto Star (CAN))
Paywalled* ճ (8/17) Physicians discuss with the Toronto Star the “all-too-common reality for children living with long COVID” that involves more than 200 symptoms “that can linger for years,” with Rachel S. Gross, MD, associate professor, Departments of Pediatrics, and Population Health, saying, “We know that (long COVID) can have long-term impacts on schooling, on ability to work in the future. These are why we need to really support children as they’re growing.”
In a separate piece in the (8/16) “Children of all ages, from infants to young adults, can develop long COVID – although the symptoms might look a bit different from adults, according to Rachel S. Gross, MD, associate professor, Departments of Pediatrics, and Population Health.”
Also reporting is the (8/17).
